Mucositis. K12.3
Conditions
Interventions
Intervention 1: Group selenium: Adminstration of selenium 400 mcg/day orally just before starting radiotherapy and continuing for 5 weeks. Intervention 2: Group placebo: Adminstration of placebo oral
Treatment - Drugs
Group selenium: Adminstration of selenium 400 mcg/day orally just before starting radiotherapy and continuing for 5 weeks
Group placebo: Adminstration of placebo orally just before starting radiotherapy and continuing for 5 weeks
Sponsors
Depeuty of Research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with diagnosis of oral;nasopharynx or hypopharynx cancer; who recieve at least 5000 centi gray radiation; at lest 2 locations of oral suitable fior radiotherapy Exclusion criteria: Patients under 18 years old
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mucosistis severity. Timepoint: Bbaseline;first week;second week;Third week;Fourth week; Fifth week. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug hypersensitivity;Headache. Timepoint: Weekly. Method of measurement: Question from patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Abbasinazari
School of pharmacy, Shahid Beheshti University of Medical Sciences
Outcome results
None listed